Acyclovir PCD Pharma Franchise Company
Cafoli Lifecare manufactures and supplies 9 Acyclovir formulations — under the Aclonist and Alycavir brands — for pharma distributors, medical agencies, stockists, and PCD franchise partners across India. The antiviral range covers oral tablets from 200mg to 800mg, hospital-grade injections, and syrup.
What is Acyclovir?
Acyclovir (aciclovir) is an antiviral medicine used to treat herpes simplex infections, genital herpes, chickenpox, and herpes zoster (shingles). It works by stopping the spread of the virus in the body (MedlinePlus, U.S. National Library of Medicine). Acyclovir is included in the WHO Model List of Essential Medicines as a core antiviral.
Our Acyclovir Product Range
| Brand | Composition | Packing | MRP |
|---|
| Aclonist 200 Tablet |
Acyclovir 200mg |
10×10 Blister |
On request |
| Alycavir 800 Tablet |
Acyclovir 800mg |
10×10 Alu Alu |
₹395 |
| Alycavir 250 Injection |
Acyclovir 250mg |
Vial + Water |
₹450 |
| Alycavir 500 Injection |
Acyclovir 500mg |
Vial + Water |
₹564 |
Plus more Acyclovir formulations including syrup — select any product above to view specifications and request pricing.
Dosage Forms Available
Tablets (200mg, 400mg, 800mg strengths), Injections (250mg, 500mg vials), and Syrup for pediatric use.
Therapeutic Applications
Acyclovir products serve herpes simplex and genital herpes management (dermatologists, gynecologists), herpes zoster and chickenpox treatment (physicians, pediatricians), herpetic eye disease support (ophthalmologists), and severe or immunocompromised infections via IV therapy in hospitals.
Why Acyclovir is a High-Potential Molecule for Distributors
Antivirals are an under-served segment in many Indian districts, and Acyclovir remains the first-line prescription for the herpes group of infections. A range spanning 200mg to 800mg tablets plus injections lets a single franchise serve retail pharmacy, dermatology clinics, and hospital supply — with limited local competition compared to crowded categories.
Why Choose Cafoli Lifecare
Monopoly rights based franchise model, WHO-GMP manufacturing, DCGI-approved portfolio, promotional inputs (visual aids, MR bags, product cards), fast dispatch, and competitive net rates — trusted by 1000+ franchise partners across India.
References
- U.S. National Library of Medicine — MedlinePlus: Acyclovir
- World Health Organization — WHO Model List of Essential Medicines
- NCBI PubChem — Acyclovir Compound Summary
Our formulations of Acyclovir find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: